Class of Stock [Axis]
Series H-7 Convertible Preferred Stock [Member]
Series I Convertible Preferred Stock [Member]
Series K Convertible Preferred Stock [Member]
Series J Convertible Preferred Stock [Member]
Series H Convertible Preferred Stock [Member]
Convertible Preferred Stock Series H-3 [Member]
Series H-6 Convertible Preferred Stock [Member]
Series K Preferred Stock [Member]
Equity Components [Axis]
Temporary Equity [Member]
Series J Preferred Stock [Member]
Series I Preferred Stock [Member]
Series H-7 Preferred Stock [Member]
Series H Preferred Stock [Member]
Preferred Stock [Member]
Series H-3 Preferred Stock [Member]
Series H-6 Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Antidilutive Securities [Axis]
Share-Based Payment Arrangement, Option [Member]
Restricted Stock Units (RSUs) [Member]
Warrant [Member]
Financial Instrument [Axis]
U.S Treasury Bills [Member]
US Government Debt Securities [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Kopin Joint Development Agreement [Member]
Series J Convertible Preferred Stock [Member]
Intangible Asset, Finite-Lived, Class [Axis]
License Right [Member]
Series H-6 Convertible Preferred Stock [Member]
Series H-7 Warrants [Member]
Series I Convertible Preferred Stock [Member]
Series I Warrants [Member]
Series I Placement Agent Warrants [Member]
Series K Preferred Stock And Warrants [Member]
Series K Warrants [Member]
Award Type [Axis]
2025 Reserse Stock Split [Member]
Series I Warrants and Series H-7 Warrants [Member]
Placement Agent Warrants [Member]
Series K Private Placement [Member]
Waiver Warrants [Member]
Altucher Consulting Agreement [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Class of Warrant or Right [Axis]
First Tranche Warrant [Member]
Second Tranche Warrant [Member]
Third Tranche Warrant [Member]
Fourth Tranche Warrant [Member]
Vesting [Axis]
Share-Based Payment Arrangement, Tranche One [Member]
First Tranche Warrants [Member]
Title and Position [Axis]
Non-Employee Director [Member]
Scenario [Axis]
Forecast [Member]
Employees [Member]
Chief Executive Officer [Member]
Restricted Stock [Member]
Derivative Instrument [Axis]
Series I Derivative Liability [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
US Treasury and Government [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
U.S. Treasury Notes – Under 90 days [Member]
U.S. Treasury Notes – Over 90 days [Member]
Anti-dilution Liability [Member]
Derivative Liability
Series I [Member]
Series H-7 [Member]
Series J Anti-dilution [Member]
Valuation Approach and Technique [Axis]
Valuation Technique, Monte Carlo Pricing Model [Member]
Measurement Input Type [Axis]
Measurement Input, Price Volatility [Member]
Measurement Input, Expected Term [Member]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Expected Dividend Rate [Member]
Measurement Input Penalty Dividend Rate [Member]
Measurement Input, Default Rate [Member]
Segments [Axis]
Segment [Member]
Related and Nonrelated Parties [Axis]
Gilbert Villarreal [Member]
Electric Power Energy [Member]
Statement Of Income Location Balances [Axis]
Research and Development Expenses [Member]
General and Administrative Expenses [Member]
Extinguishment of Debt [Axis]
Accrued Expenses and Other Current Liabilities [Member]
Asset Purchase Agreement [Member]
Joint Development and License Agreement [Member]
Murray Consulting Agreement [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Statement [Table]
Statement [Line Items]
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Marketable securities
Prepaid expenses and other current assets
Total current assets
Operating lease – right-of-use asset
Intangible assets
Digital assets
Deposits and other assets
Total assets
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Current portion lease obligation – operating lease
Total current liabilities
Derivative liability
Anti-dilution liability
Lease obligation - operating lease, net of current portion
Total liabilities
Mezzanine equity:
Redeemable preferred stock, value
Stockholders’ equity:
Preferred stock, value
Common Stock, ($0.0001 par value; authorized – 1,200,000,000 and 200,000,000 shares as of June 30, 2026, and December 31, 2025, respectively; issued and outstanding – 6,663,912 and 1,455,975 shares as of June 30, 2026, and December 31, 2025, respectively)
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities, mezzanine equity and stockholders’ equity
Temporary stock, par value
Temporary stock, stated value per share
Temporary stock, shares authorized
Temporary stock, shares issued
Temporary stock, shares outstanding
Temporary stock, liquidation preference
Preferred stock, shares authorized
Preferred stock, par value
Preferred stock, shares issued
Preferred stock, shares outstanding
Preferred stock, liquidation preference
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Revenue
Cost of goods sold
Gross loss
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Interest income
Change in fair value - warrant liability
Change in fair value - derivative liability
Change in fair value - anti-dilution liability
Unrealized gain (loss) on marketable securities
Change in fair value of digital assets
Realized gain on marketable securities
Consent and waiver fee - Series H-7
Gain on sale of assets
Other income (expense), net
Total other income (expense), net
Net loss prior to provision for income taxes
Provision for income taxes
Net loss
Dividends earned on convertible preferred stock
Accretion of discounts to redemption value of Series I and Series H-7 convertible preferred stock
Net loss attributable to common stockholders
Net loss per share basic
Net loss per share diluted
Basic weighted average Common Stock outstanding
Diluted weighted average Common Stock outstanding
Balance
Balance, shares
Deemed dividend
Preferred stock dividends
Accretion of discounts to redemption value of Series H-7 convertible preferred stock
Issuance of consultant warrants
Net income (loss)
Stock based compensation
Issuance of convertible preferred stock, net of discounts and transaction costs
Issuance of convertible preferred stock, net of discounts and transaction costs, shares
Preferred stock redemptions and conversion including cash premium
Preferred stock redemptions and conversions including cash premium, shares
Accretion of discounts to redemption value of Series I convertible preferred stock
Common stock issued for exercise of Series H-7 Preferred warrants
Common stock issued for exercise of Series H-7 Preferred warrants, shares
Common stock issued for exercise of Series I Preferred warrants
Common stock issued for exercise of Series I Preferred warrants, shares
Amendment modification
Warrant modification
Issuance of Series H-7 and Series I waiver warrants
Issuance of round up shares
Issuance of round up shares, shares
Balance
Balance, shares
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Series H-7 preferred stock waiver
Non-cash financing expense related to Series H-7 and Series I convertible preferred stock
Gain on sale of assets
Change in fair value - derivative liability
Change in fair value - warrant liability
Change in fair value - anti-dilution liability
Amortization of right-of-use asset
Change in fair value of digital assets
Unrealized loss on marketable securities
Realized gain on marketable securities
Change in operating assets and liabilities:
Prepaid expenses and other current assets
Deposits and other assets
Accounts payable
Accounts payable - related party
Accrued expenses and other current liabilities
Lease obligations - operating leases
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of marketable securities, net
Proceeds from sale of digital assets
Purchase of marketable securities
Investment in Kopin license rights
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of preferred stock (K), net of transaction costs
Proceeds from exercise of Series H-7 and Series I preferred warrants
Payment of preferred stock dividends (Series H-7 and Series I)
Net cash provided by (used in) financing activities
Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental disclosure of cash and non-cash transactions:
Common stock issued for cashless conversion of Series H-7 and Series I convertible preferred stock
Accrual of Series H-7 convertible preferred stock dividends
Accretion of discounts to redemption value of I convertible preferred stock
Accrual of Series I Convertible Preferred Stock Dividends
Deemed dividend Series H-7 warrants
Accretion of discounts to redemption value of H-7 convertible preferred stock
Accrued Series H-7 preferred stock redemption payable
Non-cash redemption of Series H-7 preferred stock
Accrued waiver fee related to Series H-7 preferred stock
Prepaid insurance financed through accrued expenses
Supplemental disclosure of restricted cash:
Cash and cash equivalents
Restricted cash
Total cash, cash equivalents and restricted cash
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Rule 10b5-1 Arrangement Modified
Non-Rule 10b5-1 Arrangement Modified
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND NATURE OF OPERATIONS
LIQUIDITY AND GOING CONCERN
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Earnings Per Share [Abstract]
BASIC AND DILUTED NET LOSS PER SHARE
Investments, Debt and Equity Securities [Abstract]
INVESTMENTS IN MARKETABLE SECURITIES
Intangible Asset, Goodwill and Other [Abstract]
INTANGIBLE ASSETS
DIGITAL ASSETS
Equity [Abstract]
STOCKHOLDERS’ EQUITY
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS
Segment Reporting [Abstract]
SEGMENT REPORTING
Leases
LEASES
Related Party Transactions [Abstract]
RELATED-PARTY TRANSACTIONS
Sale Of Legacy Electric Vehicle Assets
SALE OF LEGACY ELECTRIC VEHICLE ASSETS
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Income Tax Disclosure [Abstract]
INCOME TAXES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation and Principles of Consolidation
Use of Estimates
Intangible Assets
Recently Issued Accounting Pronouncements Not Yet Adopted
SCHEDULE OF DILUTIVE SECURITIES EXCLUDED FROM THE COMPUTATION OF WEIGHTED AVERAGE SHARES OUTSTANDING
SCHEDULE OF INVESTMENTS TRADING SECURITIES
SCHEDULE OF INTANGIBLE ASSETS
SCHEDULE OF DIGITAL ASSET HOLDINGS
SCHEDULE OF INITIAL ACCOUNTING TRANSACTION
SCHEDULE OF ALLOCATION OF PRIVATE PLACEMENT
SCHEDULE OF FAIR VALUE OF COMPANY’S EMBEDDED DERIVATIVES
SCHEDULE OF FAIR VALUE ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS
SCHEDULE OF CHANGE IN FAIR VALUE DERIVATIVE LIABILITY
SCHEDULE OF MONTE CARLO SIMULATION MODEL INPUTS AND VALUATION TECHNIQUES
SCHEDULE OF CONSOLIDATED STATEMENTS OF OPERATIONS
SCHEDULE OF SUBLEASE INCOME
SCHEDULE OF RELATED-PARTY INCURRED EXPENSES AND LIABILITIES
Marketable securities
Subsequent Event [Table]
Subsequent Event [Line Items]
Gross proceeds
Net loss
Cash flow used in operations
Working capital
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Totals
Marketable Securities [Table]
Marketable Securities [Line Items]
Total U.S. Treasury Securities
Total Trading Securities
Unrealized gain on marketable securities
ScheduleOfIntangibleAssetsTable [Table]
ScheduleOfIntangibleAssetsLineItems [Line Items]
Gross carrying amount
Beginning balance at January 1, 2026
Change in fair value
Sale of digital assets
Ending balance at June 30, 2026
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Intangible Assets, Current
Fair Value of Assets Acquired
Direct Operating Costs
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Series J Preferred Stock, at issuance date fair value (temporary equity)
Anti-dilution liability, at issuance date fair value (Note 8 and 11)
Transaction costs directly attributable to the asset acquisition
Intnagible asset recognized (acquired license right) (Note 6)
Warrants and Rights Outstanding
[custom:WarrantsFairValuePercentage]
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants
Payments of Stock Issuance Costs
Warrants and Rights Outstanding
Conversion price
Aggregate issued and outstanding shares percentage
Preferred stock, designated
Preferred stock, conversion price description
Conversion price
Temporary equity shares designated
Temporary equity, shares par value
Preferred stock, stated value
Conversion price shares
Proceeds from sale of convertible preferred stock
Stock price
Exercise price
Cash paid for accrued waiver fee
Consent and waiver fee
Accrued preferred stock redemption payable
Issuance of shares
Preferred stock, discount on shares
Estimated fair value of derivative
Payments of issuance cost
Fair value of warrant
Deemed dividend
Conversion of preferred stock
Preferred dividends
Accrued deemed dividends
Aggregate exercisable shares of common stock
Issuance of warrants to purchase of common stock
Proceeds from issuance of warrants
Fair value of preferred stock
Expected volatility
Expected term
Risk-free interest rate
Dividend yield
Penalty Dividend rate
Probability rate percentage
Payment of financing and stock issuance costs
Financing costs
Deemed dividends
Preferred dividends
Number of shares issued
Asset acquisition, non-cash consideration
Asset acquisition, liability
Asset acquisition, transaction cost
Asset acquisition, Intangible assets
Aggregate amount
Anti-dilution adjustment
Anti-dilutive provisions against cash issuance cap
Anti-dilutive liability
Anti-dilutive liability outstanding
Carrying amount
Temporary Equity, Shares Issued
Proceeds from Issuance of Preferred Stock and Preference Stock
Preferred Stock, Value, Outstanding
[custom:AlloctaedIssuanceCost]
Proceeds from issuance of stock
Payments for private placement
Offering costs
Warrants issued
Accrued dividend
Warrants outstanding
Number of shares issued
Warrants term
Exercise price
Number of shares vested
Reclassification of warrants liability to equity
Change in fair value as a non-cash loss on warrant
Share price per share
Warrants outstanding
Other expenses
Issuance of warrants to purchase of common stock
Stock-based compensation
Incremental fair value
Prepaid Expense
Unrecognized grant date fair value
Unrecognized grant date fair value
Prepaid expenses
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock options, grant
Exercise price
Contractual Term
Option vested percentage
Aggregate fair value
Exercise price
Restricted shares of common stock
Fair value price
Derivative Instruments, Gain (Loss) [Table]
Derivative Instruments, Gain (Loss) [Line Items]
Total
Change in fair value derivative liability
Fair Value, off-Balance-Sheet Risk [Table]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Total
Beginning balance
Change in fair value, three months ended March 31, 2026
Change in fair value, April 1, 2026 through Omnibus Amendment Date
Settlement of derivative liability upon Omnibus Amendment
Issuance of derivative liability upon Omnibus Amendment
Issuance of Series J Preferred Stock
Issuance of shares in settlement of anti-dilution provisions
Change in fair value
Change in fair value, Omnibus Amendment date through June 30, 2026
Ending balance
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative measurement input
Time to maturity
Bifurcated embedded derivative
Issuance of outstanding options
Change in fair value of the anti-dilution liability
Consulting expenses
Personnel expenses
Other expenses
Segment Reporting [Table]
Segment Reporting [Line Items]
Number of operating segment
Number of reportable segment
Other income (expense)
Schedule Of Sublease Income
Sublease income
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Related party incurred expenses
Related-party liabilities
Services fee
Aggregate consideration
Aggregate consideration paid
Aggregate consideration payable
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Payment for research and development
Issuance of initial public offering
Non-refundable advance payment
Unamortized advance
Research and development expense
Granted stock option
Share price
Non Rule 10b5-1 Arrangement Modified [Flag]
Rule 10b5-1 Arrangement Modified [Flag]
Series K Convertible Preferred Stock [Member]
Series J Convertible Preferred Stock [Member]
Series H-7 Convertible Preferred Stock [Member]
Series I Convertible Preferred Stock [Member]
Convertible Preferred Stock Series H-3 [Member]
Temporary equity stated value per share.
Series H Convertible Preferred Stock [Member]
Series H-6 Convertible Preferred Stock [Member]
U.S. Treasury Notes – Under 90 days [Member]
U.S. Treasury Notes – Over 90 days [Member]
Anti-dilution Liability [Member]
Consent and waiver fee.
Joint Development and License Agreement [Member]
Change in fair value of digital assets.
Change in fair value anti-dilution liability.
Accrual of series H-7 convertible preferred stock dividends.
Accrual of series I convertible preferred stock dividends.
Deemed dividend series H seven warrants.
Accrued series H 7 preferred stock redemption payable.
Series preferred stock waiver.
Accretion of discounts to redemption value of Series I convertible preferred stock.
Accretion of discounts to redemption value of series H 7 convertible preferred stock
Noncash redemption of convertible preferred stock.
Prepaid insurance financed through accrued expenses.
Accrued waiver fee related to preferred stock.
Tabular disclosure of input and valuation technique used to measure derivative fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.
Measurement Input Penalty Dividend Rate [Member]
Change in fair value of the anti-dilution liability.
Consulting expenses.
Personnel expenses.
Segment [Member]
Gilbert Villarreal [Member]
Series I Preferred Stock [Member]
Temporary Equity [Member]
Series K Preferred Stock [Member]
Series J Preferred Stock [Member]
Series H-7 Preferred Stock [Member]
Series H-3 Preferred Stock [Member]
Series H-6 Preferred Stock [Member]
Adjustments to additional paid in capital deemed dividends.
Non-refundable advance payment.
Stock issued during period value preferred stock redemptions and conversions including cash premium.
Stock issued during period shares preferred stock redemptions and conversions including cash premium.
Accretion of discounts to redemption value of Series I convertible preferred stock.
Common stock issued for exercise of Series H-7 Preferred warrants.
Common stock issued for exercise of Series H-7 Preferred warrants shares.
Common stock issued for exercise of Series I Preferred warrants.
Common stock issued for exercise of Series I Preferred warrants shares.
Amendment modification.
Warrant modification.
Issuance of Series H-7 and Series I waiver warrants.
Series I [Member]
Series H-7 [Member]
Series J Anti-dilution [Member]
Working capital.
Amendment date.
Fair value issuance of stock.
Change in fair value second amendment date.
Sale of Legacy Electric Vehicle Assets [Text Block]
Series H-6 Convertible Preferred Stock [Member]
Series H-7 Warrants [Member]
Accrued deemed dividends.
Non-Employee Director [Member]
Series I Convertible Preferred Stock [Member]
Series I Warrants [Member]
Employees [Member]
Share based compensation arrangement by share based payment award fair value assumptions probability rate percentage.
Series I financig costs.
Series I Placement Agent Warrants [Member]
Deemed dividends.
Assets of disposal group including discontinued operation paid.
2025 Reserse Stock Split [Member]
Reclassification of warrants liability to equity.
Series I Warrants and Series H-7 Warrants [Member]
Change in fair value as noncash loss on warrant.
Series K Warrants [Member]
Placement Agent Warrants [Member]
Waiver Warrants [Member]
Altucher Consulting Agreement [Member]
First Tranche Warrant [Member]
Second Tranche Warrant [Member]
Third Tranche Warrant [Member]
Fourth Tranche Warrant [Member]
First Tranche Warrants [Member]
U.S Treasury Bills [Member]
Series I Derivative Liability [Member]
Electric Power Energy [Member]
Statement Of Income Location Balances [Axis]
Research and Development Expenses [Member]
General and Administrative Expenses [Member]
Accrued Expenses and Other Current Liabilities [Member]
Asset Purchase Agreement [Member]
Accrued preferred stock redemption payable.
Share based compensation arrangement by share based payment award fair value assumptions penalty dividend rate.
Kopin Joint Development Agreement [Member]
Series J Convertible Preferred Stock [Member]
Crypto asset fair value change in fair value.
Crypto asset fair value sale of digital assets.
Antidilution liability.
Antidilution liability outstanding.
Alloctaed issuance cost
Warrants fair value percentage.
Private Placement Proceeds and Issuance Costs [Table Text Block]
Accrued dividend.
Unrecognized grant date fair value.
Incremental fair value
Proceeds from issuance of preferred stock.
Series K Private Placement [Member]
License Right [Member]
Series K Preferred Stock and Warrants [Member]
Preferred stock dividends.
Series J Convertible Preferred Stock [Member] [Default Label]
Series H-6 Convertible Preferred Stock [Member] [Default Label]
Series I Convertible Preferred Stock [Member] [Default Label]
Assets, Current
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Preferred Stock Dividends, Income Statement Impact
Temporary Equity, Accretion to Redemption Value, Adjustment
Net Income (Loss) Available to Common Stockholders, Basic
Shares, Outstanding
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings
Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Deposit Assets
Increase (Decrease) in Accounts Payable, Trade
Increase (Decrease) in Accrued Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Marketable Securities
Payment for (Proceeds from) Other Investing Activity
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Payments of Ordinary Dividends, Preferred Stock and Preference Stock
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
AccretionOfDiscountsToRedemptionValueOfSeriesIConvertiblePreferredStock
AccretionOfDiscountsToRedemptionValueOfSeriesH7ConvertiblePreferredStock
Restricted Cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Marketable Securities
Warrants and Rights Outstanding
Common Stock, Convertible, Conversion Price, Increase
Preferred Stock Dividends and Other Adjustments
PreferredStockDividends
Sale of Stock, Number of Shares Issued in Transaction
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Share-Based Payment Arrangement, Expense
IncrementalFairValue
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease)